BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33086147)

  • 1. Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study.
    Li SJ; Zhao L; Wang HY; Zhou HN; Ju J; Du H; Che GW
    Int J Surg; 2020 Dec; 84():25-40. PubMed ID: 33086147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naples Prognostic Score as a novel prognostic prediction tool in video-assisted thoracoscopic surgery for early-stage lung cancer: a propensity score matching study.
    Li S; Wang H; Yang Z; Zhao L; Lv W; Du H; Che G; Liu L
    Surg Endosc; 2021 Jul; 35(7):3679-3697. PubMed ID: 32748268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel systemic inflammation response index to predict prognosis after thoracoscopic lung cancer surgery: a propensity score-matching study.
    Li S; Yang Z; Du H; Zhang W; Che G; Liu L
    ANZ J Surg; 2019 Nov; 89(11):E507-E513. PubMed ID: 31667974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-Glutamyl Transpeptidase to Platelet Ratio Is a Novel and Independent Prognostic Marker for Resectable Lung Cancer: A Propensity Score Matching Study.
    Zhao L; Li S; Ju J; Zhou H; Wang H; Che G
    Ann Thorac Cardiovasc Surg; 2021 Jun; 27(3):151-163. PubMed ID: 33536389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid to lymphocyte ratio: A novel prognostic biomarker for surgically resected early-stage lung cancer. A propensity score matching analysis.
    Yang Z; Li S; Zhao L; Lv W; Ju J; Zhang W; Li J; Che G
    Clin Chim Acta; 2020 Apr; 503():35-44. PubMed ID: 31926813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
    Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
    Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study.
    Shangguan J; Huang X; Liu X; Zhang Z; Zhang X; Yu J; Chen D
    Front Oncol; 2023; 13():1195499. PubMed ID: 37205200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A commentary on "Gustave Roussy immune score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study".
    Xiaoyun Lin MM; Liu H
    Int J Surg; 2021 May; 89():105947. PubMed ID: 33887493
    [No Abstract]   [Full Text] [Related]  

  • 9. Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis.
    Tian S; Cao Y; Duan Y; Liu Q; Peng P
    Front Oncol; 2021; 11():737283. PubMed ID: 34917499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A commentary on "Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study" (Int J Surg 2020; 84: 25-40).
    Zhu H; Zhao G
    Int J Surg; 2021 Jul; 91():105990. PubMed ID: 34116255
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic Inflammation Score as a Novel Prognostic Indicator for Patients Undergoing Video-Assisted Thoracoscopic Surgery Lobectomy for Non-Small-Cell Lung Cancer.
    Li S; Zhang W; Yang Z; Li Y; Du H; Che G
    J Invest Surg; 2021 Apr; 34(4):428-440. PubMed ID: 31304810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
    Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
    Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity score-matching analysis of hybrid video-assisted thoracoscopic surgery and thoracoscopic lobectomy for clinical stage I lung cancer†.
    Iwata H; Shirahashi K; Yamamoto H; Marui T; Matsumoto S; Mizuno Y; Matsumoto M; Mitta S; Miyamoto Y; Komuro H
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1063-7. PubMed ID: 26324682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Short- and Long-term Outcomes of Video-assisted Thoracoscopic Surgery versus Open Thoracotomy Bronchial Sleeve Lobectomy for Central Lung Cancer: A Retrospective Propensity Score Matched Cohort Study.
    Yang Y; Mei J; Lin F; Pu Q; Ma L; Liu C; Zhu Y; Guo C; Xia L; Liu L
    Ann Surg Oncol; 2020 Oct; 27(11):4384-4393. PubMed ID: 32642997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases.
    Stephens N; Rice D; Correa A; Hoffstetter W; Mehran R; Roth J; Walsh G; Vaporciyan A; Swisher S
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):607-13. PubMed ID: 24603446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer.
    Minami S; Ihara S; Ikuta S; Komuta K
    World J Oncol; 2019 Apr; 10(2):90-100. PubMed ID: 31068989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
    Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
    Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy.
    Yang HX; Woo KM; Sima CS; Bains MS; Adusumilli PS; Huang J; Finley DJ; Rizk NP; Rusch VW; Jones DR; Park BJ
    Ann Surg; 2017 Feb; 265(2):431-437. PubMed ID: 28059973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.
    Yang CF; Meyerhoff RR; Mayne NR; Singhapricha T; Toomey CB; Speicher PJ; Hartwig MG; Tong BC; Onaitis MW; Harpole DH; D'Amico TA; Berry MF
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1615-23. PubMed ID: 26719408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: a propensity score-matched analysis.
    Dziedzic R; Marjanski T; Binczyk F; Polanska J; Sawicka W; Rzyman W
    Eur J Cardiothorac Surg; 2018 Sep; 54(3):547-553. PubMed ID: 29547899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.